Advertisement
Advertisement

TTRX

T

Turn Therapeutics Inc. Common Stock

6.16
USD
Sponsored
+0.38
+6.20%
Jun 16, 15:59 UTC -4
Closed
exchange

Pre-Market

6.15

-0.01
-0.16%

TTRX Earnings Reports

Positive Surprise Ratio

TTRX beat 0 of 1 last estimates.

0%

Next Report

Date of Next Report
Jun 25, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/
-$0.03
Implied change from Q1 26 (Revenue/ EPS)
--
/
+50.00%
Implied change from Q2 25 (Revenue/ EPS)
--
/
--

Turn Therapeutics Inc. Common Stock earnings per share and revenue

On May 11, 2026, TTRX reported earnings of -0.02 USD per share (EPS) for Q1 26, missing the estimate of -0.02 USD, resulting in a -1.96% surprise. Revenue reached --, compared to an expected --, with a --% difference. The market reacted with a +2.58% price change (close before vs. close after earnings).
Looking ahead to Q2 26, -- analysts forecast an EPS of -0.03 USD, with revenue projected to reach -- USD, implying an increase of 50.00% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Greenwich LifeSciences, Inc.
Report Date
Jun 04, 2026 For Q1 26
Estimate
-$0.33
Actual
-$0.39
Surprise
-15.86%
logo
Vistagen Therapeutics, Inc. Common Stock
Report Date
Jun 15, 2026 For Q4 26
Estimate
-$0.34
Actual
-$0.37
Surprise
-7.75%
FAQ
For Q1 2026, Turn Therapeutics Inc. Common Stock reported EPS of -$0.02, missing estimates by -1.96%, and revenue of --, -- -- expectations.
The stock price moved up 2.58%, changed from $3.88 before the earnings release to $3.98 the day after.
The next earning report is scheduled for Jun 25, 2026.
Based on -- analysts, Turn Therapeutics Inc. Common Stock is expected to report EPS of -$0.03 and revenue of -- for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement